Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK

Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth

15-Nov-2024
Waters Corporation

Leaders celebrating the opening of Waters site in Longbridge, United Kingdom at a ribbon cutting event in November 2024.

Waters Corporation announced the official opening of its new 45,000 square foot manufacturing facility at the Longbridge Business Park in the West Midlands. The new facility more than triples existing operations and enhances the company's machining capacity to produce critical components for products developed and manufactured at Waters mass spectrometry Center of Excellence in Wilmslow, UK and in Wexford, Ireland.

The new Waters facility at Longbridge represents a significant investment in the region, underscoring the company's commitment to maintaining and growing its local manufacturing capabilities and capacity.

"The opening of our Longbridge facility is an important next step for Waters and our employees with a modern, fit-for-purpose space to support their innovative and important work," said Chris Ross, Senior Vice President of Global Operations at Waters. "This state-of-the-art precision engineering center expands our manufacturing footprint in the region and also provides a highly desirable working environment to support future growth and the potential for additional skilled jobs."

"The UK Government is delighted that Waters Corporation is opening a new site at Longbridge. This investment brings new jobs and innovative new technology in precision engineering into the West Midlands – an area that has long welcomed industrial innovation," said David Clay, British Consul General to New England. "The fact that a leading company like Waters has chosen the UK for this investment is also a great endorsement of the UK talent available in this sector, and we look forward to seeing the new facility have a long-term positive effect in the West Midlands Region."

Products manufactured at the new site in Longbridge are essential components used in Waters mass spectrometry systems – scientific instruments used by tens of thousands of chemists and analytical scientists worldwide in support of the life, food, environmental, and materials sciences. 

The Longbridge facility is a testament to Waters dedication to sustainability. The building, developed by St. Modwen with internal fit-out completed by Briggs & Forrester Engineering Services, was constructed to BREEAM Very Good standard and achieved an Energy Performance Certificate rating of "A." Key building features include the heating and hot water systems designed to consume zero natural gas and the temperature-controlled production environment allows manufacturing to sub-micron accuracy.

Other news from the department manufacturing

Most read news

More news from our other portals

See the theme worlds for related content

Topic World Mass Spectrometry

Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

4 products
4 brochures
View topic world
Topic World Mass Spectrometry

Topic World Mass Spectrometry

Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

4 products
4 brochures

Last viewed contents

Enduro Genetics raises €12 million to unlock the future of scalable bioproduction - Patented cell reprogramming technology "addicts" cells to high production and integrates seamlessly into any microbial bioproduction host

Enduro Genetics raises €12 million to unlock the future of scalable bioproduction - Patented cell reprogramming technology "addicts" cells to high production and integrates seamlessly into any microbial bioproduction host

Simtra BioPharma Solutions - Parsippany, USA

Simtra BioPharma Solutions - Parsippany, USA

Boehringer Ingelheim to acquire NBE-Therapeutics - Boehringer Ingelheim Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates

Boehringer Ingelheim to acquire NBE-Therapeutics - Boehringer Ingelheim Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates

European Medicines Agency recommends that Linoladiol N and Linoladiol HN remain available - Benefits continue to outweigh risks with new restrictions

Advises on compassionate use of a new combination therapy for chronic hepatitis C - Combination of ledipasvir and sofosbuvir to be used in patients in urgent need of therapy to prevent progression of liver disease

EMA recommends approval of new treatment for platinum-resistant ovarian cancer - Vynfinit (vintafolide) offers treatment for women with limited therapeutic options; two diagnostic medicines recommended for approval will help identify patients most likely to respond

EMA endorses revised policy on handling of declarations of interests

Recommendation against combined use of medicines affecting the renin-angiotensin system

UK Agency’s Update on “Three-Person IVF” Leaves Safety Questions Unresolved - Parliamentary Vote Would be Premature, Says Public Interest Group

EMA to relocate to Amsterdam - Working with Dutch government to ensure successful move by end of March 2019

BIO Urges EPA to Fully Consider Impacts of Renewable Fuel Standard Waiver Requests

From Promise to Productivity: Smart Policy for Sustainable EU Growth Through Biobased Products and Industrial Biotechnology